Data / Form D filings / Sermonix Pharmaceuticals, Inc.
Sermonix Pharmaceuticals, Inc.: Form D filings
Sermonix Pharmaceuticals, Inc., a pharmaceuticals company in Columbus, OH, filed 3 Form D notices with the SEC between 2015 and 2021. The latest, on November 23, 2021, reports $40.2 million sold of a $40.2 million offering to 9 investors.
Find out what Sermonix Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3000 E. MAIN ST, Columbus, OH, 43209
- Phone
- (614) 864-4919
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1655566
The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | New notice | $40,225,000 | $40,225,000 | $0 | 9 | Nov 12, 2021 | sec.gov |
| Jul 11, 2016 | New notice | $2,500,000 | $1,550,000 | $950,000 | 2 | Jul 5, 2016 | sec.gov |
| Oct 14, 2015 | New notice | $3,000,000 | $1,020,000 | $1,980,000 | 17 | Sep 28, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony Wild | Executive Officer, Director | |
| Miriam Portman | Executive Officer, Promoter | |
| Elizabeth Attias | Executive Officer | |
| Michael Friedman | Director | |
| Simon Jenkins | Executive Officer | |
| Elizabeth Garner | Director | |
| David Portman | Executive Officer, Director, Promoter | |
| Richard De Schutter | Director | |
| Barry Komm | Executive Officer | |
| Thomas Pfisterer | Director | |
| Paul Plourde | Executive Officer |
Other pharmaceuticals companies in Ohio that filed recently
- EIKONOKLASTES THERAPEUTICS, INC. $16.1 million · Oct 6, 2026
Every Form D from the week of Nov 22, 2021 · All recent filings in Ohio · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sermonix Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.